Uciane Scarlett

Uciane Scarlett, Ph.D. is a Principal at MPM BioImpact, a leading life sciences venture firm.3 In her role, she is responsible for investment identification, due diligence, business development, and new company creation.2

Educational Background

Dr. Scarlett holds a Ph.D. in Cancer Immunology from the Geisel School of Medicine at Dartmouth, which she completed between 2006 and 2011.5 Prior to her doctoral studies, she earned a B.Sc. with First Class honors.5

Professional Experience

At MPM BioImpact, Uciane Scarlett is part of a team that creates and invests in biotech companies developing innovative, life-saving drugs for patients.1 The firm focuses on both private and public companies, providing a unique perspective on drug development across the industry.1

Investment Focus

As a Principal at MPM BioImpact, Dr. Scarlett's investment range typically falls between $100,000 and $5 million, with a sweet spot around $1.5 million.4 She has been involved in at least four investments on record.4

Additional Roles

Uciane Scarlett is also connected to Yale Ventures, an organization that helps develop innovations that impact the world's greatest challenges.6 This association suggests her involvement in fostering innovation beyond her primary role at MPM BioImpact.

Dr. Scarlett's expertise in cancer immunology, combined with her experience in venture capital, positions her as a valuable asset in identifying and supporting promising biotech ventures, particularly those focused on developing novel therapeutics and advancing medical research.